Ironwood Pharmaceuticals
IRWD
$7.65
Share price
-3.04%
Change (1 day)
-31.88%
Change (1 year)
Categories
Operating Margin for Ironwood Pharmaceuticals (IRWD)
Operating Margin as of April 2024 (TTM): 62.76%
According to Ironwood Pharmaceuticals 's latest financial reports and stock price the company's current Operating Margin is 62.76%. At the end of 2021 the company had an Operating Margin of 48.50%.
Operating Margin history for Ironwood Pharmaceuticals from 2009 to 2023
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2021 | 48.50% | 73.53% |
| 2020 | 27.95% | 103.13% |
| 2019 | 13.76% | -116.89% |
| 2018 | -81.46% | 107.78% |
| 2017 | -39.20% | 31.45% |
| 2016 | -29.83% | -68.74% |
| 2015 | -95.40% | -61.55% |
| 2014 | -248.07% | -79.19% |
| 2013 | -1,192.31% | 2366.65% |
| 2012 | -48.34% | -50.9% |
| 2011 | -98.45% | -27.26% |
| 2010 | -135.34% | -33.62% |
| 2009 | -203.89% | -17.69% |
| 2008 | -247.71% | -51.24% |
| 2007 | -508.03% |
Operating Margin for similar companies or competitors
| Company | Operating Margin | Operating Margin differencediff. | Country |
|---|---|---|---|
 AstraZeneca AZN | 5.63% | -91.03% | 🇬🇧 UK |
 Nektar Therapeutics
NKTR | -396.48% | -731.74% | 🇺🇸 USA |
What is a company's Operating Margin
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.